Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Invesco S&P 500 Revenue ETF
RWL
|
+$658M |
| 2 |
Tesla
TSLA
|
+$573M |
| 3 |
Bank of America
BAC
|
+$480M |
| 4 |
Amazon
AMZN
|
+$448M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$445M |
Top Sells
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$493M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$395M |
| 3 |
Eli Lilly
LLY
|
+$364M |
| 4 |
CME Group
CME
|
+$316M |
| 5 |
T-Mobile US
TMUS
|
+$310M |
Sector Composition
| 1 | Technology | 23.42% |
| 2 | Financials | 13.31% |
| 3 | Industrials | 11.27% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Discretionary | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Erasca
ERAS
$440M
| $156K | ﹤0.01% |
113,583
+64,912
| +133% | +$88.9K |
|
3477
Aquestive Therapeutics
AQST
$602M
| $154K | ﹤0.01% |
53,096
+5,152
| +11% | +$14.9K |
|
3478
Gores Guggenheim
PSNY
$2.14B
| $154K | ﹤0.01% |
146,238
+134,019
| +1,097% | +$141K |
|
3479
Lifetime Brands
LCUT
$93.3M
| $153K | ﹤0.01% |
30,969
-8,710
| -22% | -$42.9K |
|
3480
MBIA
MBI
$386M
| $152K | ﹤0.01% |
30,453
-7,404
| -20% | -$36.9K |
|
3481
Entrada Therapeutics
TRDA
$201M
| $151K | ﹤0.01% |
16,691
+5,187
| +45% | +$46.9K |
|
3482
Mizuho Financial
MFG
$82.4B
| $151K | ﹤0.01% |
27,375
+418
| +2% | +$2.3K |
|
3483
Coherus Oncology, Inc. Common Stock
CHRS
$159M
| $151K | ﹤0.01% |
186,721
+120,670
| +183% | +$97.4K |
|
|
ZH
3484
Zhihu
ZH
$442M
| $150K | ﹤0.01% |
35,056
-4,556
| -12% | -$19.5K |
|
3485
Talkspace
TALK
$447M
| $149K | ﹤0.01% |
58,213
-2,842
| -5% | -$7.28K |
|
|
AVR
3486
Anteris Technologies Global Corp. Common Stock
AVR
$167M
| $149K | ﹤0.01% |
+40,911
| New | +$149K |
|
3487
Solid Biosciences
SLDB
$389M
| $149K | ﹤0.01% |
40,180
+27,943
| +228% | +$103K |
|
3488
Purple Innovation
PRPL
$118M
| $148K | ﹤0.01% |
195,205
-62,072
| -24% | -$47.1K |
|
|
SVM
3489
Silvercorp Metals
SVM
$1.09B
| $148K | ﹤0.01% |
38,242
-11,060
| -22% | -$42.8K |
|
|
BBBY
3490
Bed Bath & Beyond, Inc.
BBBY
$638M
| $148K | ﹤0.01% |
25,500
-770,945
| -97% | -$4.47M |
|
3491
Semrush
SEMR
$1.16B
| $145K | ﹤0.01% |
15,498
-577
| -4% | -$5.38K |
|
|
LUCK
3492
Lucky Strike Entertainment Corporation
LUCK
$1.41B
| $144K | ﹤0.01% |
+14,786
| New | +$144K |
|
3493
Y-mAbs Therapeutics
YMAB
$390M
| $144K | ﹤0.01% |
32,547
+17,624
| +118% | +$78.1K |
|
3494
Zevra Therapeutics
ZVRA
$468M
| $142K | ﹤0.01% |
19,022
+638
| +3% | +$4.78K |
|
3495
Aemetis
AMTX
$143M
| $141K | ﹤0.01% |
81,256
+64,115
| +374% | +$112K |
|
|
WW
3496
DELISTED
WW International
WW
| $141K | ﹤0.01% |
269,910
-79,527
| -23% | -$41.6K |
|
3497
Acumen Pharmaceuticals
ABOS
$87.2M
| $141K | ﹤0.01% |
127,798
+107,956
| +544% | +$119K |
|
3498
UroGen Pharma
URGN
$991M
| $141K | ﹤0.01% |
12,710
-746
| -6% | -$8.25K |
|
3499
Evolv Technologies
EVLV
$1.44B
| $137K | ﹤0.01% |
43,866
-2,203
| -5% | -$6.87K |
|
3500
Noodles & Co
NDLS
$30.9M
| $136K | ﹤0.01% |
125,126
-20,076
| -14% | -$21.9K |
|